In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azitbromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine)

被引:27
作者
Hoppe, JE
Bryskier, A
机构
[1] Univ Tubingen, Childrens Hosp, D-72070 Tubingen, Germany
[2] Hoechst Mar Roussel, F-93235 Romainville, France
关键词
D O I
10.1128/AAC.42.4.965
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
When tested by agar dilution on Mueller-Hinton agar supplemented with 5% horse blood, the ketolides HMR 3004 and HMR 3647 were slightly more active (MIC at which 90% of the isolates were inhibited [MIC90], 0.03 mu g/ml) against Bordetella pertussis than azithromycin, clarithromycin, erythromycin A, and roxithromycin. Azithromycin (MIC90, 0.06 mu g/ml) was the most active compound against B. parapertussis. Rifampin and rifapentine were considerably less active.
引用
收藏
页码:965 / 966
页数:2
相关论文
共 11 条
[11]   SUSCEPTIBILITY OF BORDETELLA-PERTUSSIS TO DOXYCYCLINE, CINOXACIN, NALIDIXIC-ACID, NORFLOXACIN, IMIPENEM, MECILLINAM AND RIFAMPICIN [J].
ZACKRISSON, G ;
BRORSON, JE ;
BJORNEGARD, B ;
TROLLFORS, B .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1985, 15 (05) :629-632